Anavex Life Sciences Corp (AVXL)

[xodcode]

If one believes that AVXL has the keys to a potentially disruptive approach to CNS disorders as recently evidenced by the anecdotal Melbourne piano and painting results, then AVXL's current price offers a most attractive entry point.

Biopharmacals in general are currently out of favour in the market and AVXL's recent weakness in such an environment should not be surprising!

Many ways to play AVXL, the 2 primary being: trading short term momentum or accumulate on weakness while holding for the longer term (i.e. 1 to 3 years).

Currently traders have been holding sway. longer term, my guess is that accumulators on weakness will steal the thunder.

My main point in this post is that AVXL may well offer long term gains that will render the current period's vacillating price meaningless....accumulate and hold would seem to offer a very attractive risk/reward ratio below $4, below $5 and below $10!